BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...

Announcement reinforces SGS’s position as one of the few European CROs offering end-to-end human ADME programs This ...

Eli Lilly announced an acquisition of an innovative new autoimmune drug.

Artificial intelligence is booming across biopharma, with deployed tech taking aim at the industry’s biggest challenges: the significant risk of failure, high costs and long development timelines. And ...

Edesa Biotech, Inc. has announced its financial results for the first half of 2025, highlighting a $15 million equity financing aimed at advancing its vitiligo drug candidate, EB06, an anti-CXCL10 ...

Zonsen PepLib Biotech Inc. ("PepLib") today announced that it has entered a global research and development (R&D) collaboration and license agreement with Eli Lilly and Company ("Lilly"). Under the ...

DUBLIN--(BUSINESS WIRE)--The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at $3.8 billion in ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced it has been named “Overall Immunology Company of the Year” in ...

Carter emphasizes that women are currently serving as primary “thought leaders” in the advancement of precision medicine . In ...